Luca Palombi: Venolymphatic Plexus Incompetence in Recurrent Varicose Veins
Luca Palombi, Vascular Surgeon and Co-Founder at Cura Vene Roma, shared a post on LinkedIn:
“Recurrent varicose veins are often attributed to neovascularization.
But is this always the correct explanation?
In my clinical experience, a subset of recurrences appears to originate from a different anatomical substrate: an incompetent venolymphatic plexus associated with an inguinal lymph node.
Rather than representing ‘new vessels’ alone, these cases seem to involve a pre-existing intranodal microvascular network that, following surgery or endovenous ablation, undergoes remodeling and progressively becomes hemodynamically significant.
The proposed mechanism is straightforward:
- Elevated pressure from the common femoral vein is transmitted into an incompetent intranodal venolymphatic plexus.
- The plexus then acts as an intermediary reflux reservoir, directing blood centrifugally into superficial tributaries.
- The result is recurrent varicose veins despite durable occlusion of the treated saphenous trunk.
On duplex ultrasound, this pattern may appear as a cluster of tortuous vessels converging within or immediately adjacent to an inguinal lymph node, demonstrating reflux during dynamic maneuvers.
Recognizing this anatomical configuration is important because treatment should focus on the refluxing venolymphatic plexus, rather than simply removing or ablating the recurrent superficial varicosities.
From a therapeutic perspective, I believe ultrasound-guided foam sclerotherapy (UGFS) represents the treatment of choice in these cases. Beyond its effectiveness in obliterating the incompetent venolymphatic network, UGFS avoids the delivery of thermal energy in close proximity to the lymph node, thereby minimizing the potential risk of thermal injury to nodal structures and the surrounding lymphatic pathways.
I would be very interested to hear your experience and discuss whether this entity should be differentiated from classical neovascularization.”

Stay updates with Hemostasis Today.
-
Nov 13, 2026, 15:10Sally Mandour: Ringed Sideroblasts in Peripheral Blood
-
Nov 13, 2026, 14:58Lorena Arranz: The Power of Patient Engagement in Advancing MPN Research
-
Nov 13, 2026, 14:46Shehab Mohamed: SGLT2 Inhibitors in Anemia Management
-
Nov 13, 2026, 14:25Dino Mehic: Targeting TFPI in Unexplained Bleeding Disorders
-
Nov 13, 2026, 14:19Bahar Artım Esen: Rituximab in Antiphospholipid Syndrome
-
Nov 13, 2026, 14:13Tagreed Alkaltham: What If One Blood Donation Could Produce Units Of Blood?
-
Nov 13, 2026, 13:27Shirley D’Sa: Connecting European and Mayo Clinic Experts in MGCS Research and Care
-
Nov 13, 2026, 13:20Josie Sirna: Representing the Thalassemia Community at Canada’s Rare Disease Conference in Halifax
-
Nov 13, 2026, 13:14Annalisa Ruggeri: 18 Years in Haematology – Celebrating a Journey at San Raffaele